Donald Tomalia
DonaldTomaliawasthescientificdirectoroftheCenterforBiologicNanotechnologyattheUniversityofMichiganMedicalSchool.HeearnedanundergraduatedegreefromtheUniversityofMichigan,amaster'sdegreefromBucknellUniversityandaPh.D.inphysicalorganicchemistryfromMichiganStateUniversity.HeworkedatDowChemicalformanyyearsasaresearchscientist.In1979,Tomaliacreatedsyntheticparticlesknownasdendrimers,whichhavebeenusedinnanotechnologyandpharmaceuticals.In1992,Tomaliafoundedhisowncompany,Dendritech.ThecompanywaspurchasedbyDowChemicalinafewyearslater.In2001,TomaliastartedDendriticNanoTechnologiesatCentralMichiganUniversity;StarpharmaofAustraliaprovidedseedmoneyfortheventureandDowtookanequitypositionafewyearslater.In2010,TomaliafoundedNanoSynthons,LLC,inMountPleasant,Michigan.In2016,hewasnamedafellowoftheAmericanAssociationfortheAdvancementofScience.HehasbeennamedaThomsonReutersCitationLaureate.